X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (451) 451
Publication (24) 24
Conference Proceeding (4) 4
Book Chapter (3) 3
Newspaper Article (3) 3
Book Review (2) 2
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (235) 235
cardiac & cardiovascular systems (204) 204
index medicus (154) 154
male (129) 129
female (128) 128
middle aged (119) 119
cardiovascular (101) 101
aged (92) 92
electrocardiography (86) 86
treatment outcome (83) 83
abridged index medicus (67) 67
mortality (54) 54
cardiology (50) 50
heart attacks (50) 50
myocardial infarction (50) 50
risk factors (49) 49
percutaneous coronary intervention (47) 47
time factors (46) 46
myocardial infarction - therapy (44) 44
myocardial infarction - physiopathology (42) 42
clinical trials (41) 41
stents (40) 40
angioplasty (37) 37
prospective studies (36) 36
heart attack (35) 35
ischemia (34) 34
internal medicine (33) 33
thrombolytic therapy (32) 32
drug-eluting stents (31) 31
thrombosis (31) 31
united states (31) 31
coronary vessels (30) 30
trial (30) 30
acute myocardial-infarction (29) 29
electrocardiography - methods (28) 28
myocardial infarction - diagnosis (28) 28
transluminal angioplasty (28) 28
cardiology and cardiovascular medicine (27) 27
angioplasty, balloon, coronary (26) 26
cardiovascular disease (26) 26
outcomes (26) 26
therapy (26) 26
cardiac patients (25) 25
coronary angiography (25) 25
risk assessment (25) 25
care and treatment (24) 24
coronary artery disease - therapy (23) 23
coronary disease - therapy (23) 23
stent (23) 23
studies (23) 23
follow-up studies (22) 22
acute coronary syndromes (21) 21
heart (21) 21
medical research (21) 21
patients (21) 21
reperfusion (21) 21
adult (20) 20
electrocardiogram (20) 20
myocardial-infarction (20) 20
registries (20) 20
heart failure (19) 19
primary angioplasty (19) 19
usage (19) 19
angiography (18) 18
angioplasty, balloon, coronary - adverse effects (18) 18
coronary heart disease (18) 18
follow-up (18) 18
medicine, general & internal (18) 18
prognosis (18) 18
analysis (17) 17
angioplasty, balloon, coronary - methods (17) 17
drug therapy (17) 17
intervention (17) 17
patient outcomes (17) 17
peripheral vascular disease (17) 17
randomized-trial (17) 17
medical equipment (16) 16
percutaneous coronary intervention - adverse effects (16) 16
percutaneous coronary intervention - methods (16) 16
platelet aggregation inhibitors - administration & dosage (16) 16
prosthesis design (16) 16
trials (16) 16
bleeding (15) 15
incidence (15) 15
myocardial infarction - drug therapy (15) 15
perfusion (15) 15
randomized controlled trials as topic (15) 15
recovery (15) 15
risk (15) 15
cardiovascular diseases (14) 14
clinical outcomes (14) 14
double-blind method (14) 14
drug therapy, combination (14) 14
electrocardiography, ambulatory (14) 14
medicine, experimental (14) 14
myocardial infarction - mortality (14) 14
myocardial reperfusion (14) 14
platelet aggregation inhibitors - adverse effects (14) 14
reproducibility of results (14) 14
retrospective studies (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, ISSN 1078-6791, 05/1999, Volume 5, Issue 3, pp. 74 - 82
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2155 - 2166
Patients who had received a drug-eluting stent and then dual antiplatelet therapy for 12 months were randomly assigned to 18 more months of therapy or aspirin... 
TRIALS | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | MULTICENTER | CLOPIDOGREL | TICAGRELOR | THROMBOSIS | RATIONALE | PREVENTION | ASPIRIN | CLINICAL-OUTCOMES | Piperazines - administration & dosage | Prasugrel Hydrochloride | Thiophenes - adverse effects | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Aspirin - administration & dosage | Incidence | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Drug Therapy, Combination | Myocardial Ischemia - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Myocardial Ischemia - therapy | Aged | Hemorrhage - chemically induced | Aggregation | Treatment outcome | Care and treatment | Usage | Blood platelets | Analysis | Drug-eluting stents | Dosage and administration | Cardiovascular diseases | Thrombosis | Health aspects | Blood clot | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Drug delivery | Patients | Bleeding | Clinical outcomes | Cerebrovascular system | Coronary vessels | Implants | Clopidogrel | Drug therapy | Stents
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9906, pp. 1714 - 1722
Journal Article